0 TSX Venture News - November 8, 2018IBEX Reports Results for the Year Ended July 31, 2018MONTRÉAL, Nov. 08, 2018 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its […]Read More
0 TSX Venture News - November 8, 2018Signature Resources Intersects High Grade Gold From Its First Drill Program in North Zone at Lingman Lake Gold ProjectDrilling highlighted by 8.0 m of 17.87 g/t gold & 4.0 m of 6.84 g/t gold in the North Zone […]Read More
0 TSX Venture News - November 8, 2018Orezone Announces Key Appointments and Provides Bomboré Development UpdateOTTAWA, Nov. 08, 2018 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSXV: ORE) (“Orezone” or the “Company”) is pleased to provide […]Read More
0 NASDAQ Companies - November 8, 2018Proteon Therapeutics to Present at the Stifel 2018 Healthcare Conference November 13thWALTHAM, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) — Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to […]Read More
0 Canadian Stock Exchange News - November 8, 2018Idaho Champion Intersects 4.80 Grams Per Tonne Gold Over 5.9 Metres in Highly Oxidized Zone at the Baner ProjectTORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) — Idaho Champion Gold Mines Canada Inc. (CSE: ITKO) (“Champion” or the “Company”), is […]Read More
0 NYSE Companies - November 8, 2018Sensata Technologies to Present at the 2018 RBC Capital Markets Technology, Internet, Media and Telecommunications ConferenceCompany to Webcast Presentation Live at 8:00 a.m. ET on Tuesday, November 13th SWINDON, United Kingdom, Nov. 08, 2018 (GLOBE […]Read More
0 NASDAQ Companies - November 8, 2018Moleculin Announces New Independent Study Expands Potential Use of Its Pancreatic Drug Candidate WP1122Documented potential for drug candidate with characteristics like WP1122 to reverse immune suppression HOUSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) — […]Read More
0 NASDAQ Companies - November 8, 2018Kura Oncology Adds Commercial Veteran Mary Szela to Board of DirectorsMs. Szela brings expertise in global brand development to Kura as company enters first registration-directed trial SAN DIEGO, Nov. 08, […]Read More
0 NASDAQ Companies - November 8, 2018Progenics Pharmaceuticals Announces Third Quarter 2018 Financial Results And Business UpdateAZEDRA® (iobenguane I 131) Approved by U.S. Food and Drug Administration (FDA) AZEDRA U.S. Launch Progressing and AZEDRA Added to the […]Read More
0 NASDAQ Companies - November 8, 2018Conatus Pharmaceuticals Announces Presentations and Posters at AASLD Annual MeetingSAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) announced today the schedule of upcoming oral […]Read More